Header Logo

Connection

Kate Lapane to Aspirin

This is a "connection" page, showing publications Kate Lapane has written about Aspirin.
Connection Strength

0.393
  1. Lapane KL, Hume AL, Barbour MM, Lipsitz LA. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure? J Am Geriatr Soc. 2002 Jul; 50(7):1198-204.
    View in: PubMed
    Score: 0.227
  2. Lapane KL, Hughes CM. Optimising drug utilisation in long term care. Pharmacoeconomics. 2002; 20(3):143-52.
    View in: PubMed
    Score: 0.055
  3. Quilliam BJ, Lapane KL. Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke. 2001 Jun; 32(6):1385-93.
    View in: PubMed
    Score: 0.053
  4. Hume AL, Barbour MM, Lapane KL, Assaf AR, Carleton RA. Prevalence and descriptors of aspirin use as an antiplatelet agent in two New England communities. Ann Pharmacother. 1993 Apr; 27(4):442-4.
    View in: PubMed
    Score: 0.030
  5. Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke. 2003 Nov; 34(11):2693-7.
    View in: PubMed
    Score: 0.016
  6. Quilliam BJ, Lapane KL, Eaton CB, Mor V. Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors. Stroke. 2001 Oct; 32(10):2299-304.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.